-
Je něco špatně v tomto záznamu ?
Antitumor and biological effects of black pine (pinus nigra) pollen nuclease
P Lipovova, T Podzimek, L Orctova, J Matousek, P Pouckova, J Soucek, J Matousek
Jazyk angličtina Země Slovensko
- MeSH
- borovice enzymologie MeSH
- embryonální vývoj účinky léků MeSH
- endonukleasy farmakologie imunologie toxicita MeSH
- endoribonukleasy farmakologie MeSH
- financování organizované MeSH
- fytogenní protinádorové látky farmakologie MeSH
- lidé MeSH
- myši inbrední ICR MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- pyl enzymologie MeSH
- spermatogeneze účinky léků MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
The antitumor effect of black pine (Pinus nigra) pollen nuclease (PN) tested in vitro was negligible in comparison with bovine seminal ribonuclease (BS-RNase). However, in the experiments in vivo a significant decrease of the human melanoma tumor size was observed in the mice treated with this nuclease and also with the animal RNases and DNase I. In nude mice injected intratumoraly with PN (10 microg/dose) the tumor size decreased from 100% in the control mice to 46% in treated mice whereas in counterparts treated with BS-RNase and DNase I the tumor growth was reduced a little more, however after ten times higher doses (100 and 80 microg per dose). Certain aspermatogenic and embryotoxic activity as an expression of side effects of PN and comparative enzymes also appeared, but it was lower compared to the effect of bovine seminal ribonuclease. Immunogenicity of PN was significantly weaker in comparison with BS-RNase. The antibodies against black pine nuclease produced in the injected mice did not inactivate the biological effects of this plant nuclease in vivo. In conclusion PN nuclease proved in vivo higher antitumor activity against human melanoma tumors growing in athymic mice in comparison with animal bovine seminal ribonuclease and DNase I.
- 000
- 02924naa 2200469 a 4500
- 001
- bmc11003985
- 003
- CZ-PrNML
- 005
- 20111210202511.0
- 008
- 110303s2008 xo e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Lipovová, Petra, $d 1975- $7 xx0078724
- 245 10
- $a Antitumor and biological effects of black pine (pinus nigra) pollen nuclease / $c P Lipovova, T Podzimek, L Orctova, J Matousek, P Pouckova, J Soucek, J Matousek
- 314 __
- $a Department of Biochemistry and Microbiology, Institute of Chemical Technology Prague, Prague, Czech Republic.
- 520 9_
- $a The antitumor effect of black pine (Pinus nigra) pollen nuclease (PN) tested in vitro was negligible in comparison with bovine seminal ribonuclease (BS-RNase). However, in the experiments in vivo a significant decrease of the human melanoma tumor size was observed in the mice treated with this nuclease and also with the animal RNases and DNase I. In nude mice injected intratumoraly with PN (10 microg/dose) the tumor size decreased from 100% in the control mice to 46% in treated mice whereas in counterparts treated with BS-RNase and DNase I the tumor growth was reduced a little more, however after ten times higher doses (100 and 80 microg per dose). Certain aspermatogenic and embryotoxic activity as an expression of side effects of PN and comparative enzymes also appeared, but it was lower compared to the effect of bovine seminal ribonuclease. Immunogenicity of PN was significantly weaker in comparison with BS-RNase. The antibodies against black pine nuclease produced in the injected mice did not inactivate the biological effects of this plant nuclease in vivo. In conclusion PN nuclease proved in vivo higher antitumor activity against human melanoma tumors growing in athymic mice in comparison with animal bovine seminal ribonuclease and DNase I.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a fytogenní protinádorové látky $x farmakologie $7 D000972
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a embryonální vývoj $x účinky léků $7 D047108
- 650 _2
- $a endonukleasy $x farmakologie $x imunologie $x toxicita $7 D004720
- 650 _2
- $a endoribonukleasy $x farmakologie $7 D004722
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední ICR $7 D008813
- 650 _2
- $a borovice $x enzymologie $7 D028223
- 650 _2
- $a pyl $x enzymologie $7 D011058
- 650 _2
- $a spermatogeneze $x účinky léků $7 D013091
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Podzimek, Tomáš $7 xx0172035
- 700 1_
- $a Orctová, L. $7 _AN059355
- 700 1_
- $a Matoušek, Josef, $d 1925- $7 jk01080797
- 700 1_
- $a Poučková, Pavla, $d 1950- $7 jo2002102951
- 700 1_
- $a Souček, Josef $7 xx0104682
- 700 1_
- $a Matoušek, Jindřich. $7 zcu2008417993
- 773 0_
- $t Neoplasma $w MED00003470 $g Roč. 55, č. 2 (2008), s. 158-164 $x 0028-2685
- 910 __
- $a ABA008 $b A 1194 $y 1
- 990 __
- $a 20110413122338 $b ABA008
- 991 __
- $a 20110413122338 $b ABA008
- 999 __
- $a ok $b bmc $g 831325 $s 696010
- BAS __
- $a 3
- BMC __
- $a 2008 $b 55 $c 2 $d 158-164 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- LZP __
- $a 2011-3B/ipme